It's coming in April 2025. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Classic-style RTS Tempest Rising has debuted a new trailer at ...

Tempest Therapeutics is laying off 21 full-time workers to retain just five, as the cash-strapped Bay Area biotech company plots its next move.

I go into more detail in my Tempest Rising review, but essentially, the RTS game is a showcase of how to structure and stagger a giant battle. I don't want to spoil anything, but there's one later ...

Tempest plans to complete the significant reduction in its head count by April 30. The biotech expects the action to cost it about $1.5 million, mainly in the form of severance payments.

Shares of Tempest Therapeutics (TPST) ended higher on Wednesday amid a broader market rebound on the U.S. pausing tariffs and extended gains after-hours after the company said it was exploring ...

Unable to secure additional financing amid a stormy market, Tempest Therapeutics has put a call out for partners as it seeks to take its liver cancer drug into phase 3.. The Brisbane, California ...

BRISBANE, Calif., June 11, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune ...

Tempest to lead Phase 3 liver cancer trial with free atezolizumab supply from Roche. Scotia Capital downgrades Tempest stock from Sector Outperform to Sector Perform. Market-moving news hits ...